Isaiah B. Kramer
Lawyers
Filters
Ionis Pharmaceuticals $500.3 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Synchrony Financial $750 million senior notes offering
The investment-grade notes are due 2030
Falabella cash tender offer
We advised Falabella on the tender offer
PGE $400 million at-the-market offering
The common stock is listed on the NYSE
Biodesix $55 million follow-on offering
The common stock is listed on the Nasdaq Global Market
Synchrony Financial $500 million preferred stock offering
The depositary shares represent an interest in the company’s 8.25% fixed-rate reset non-cumulative perpetual preferred stock